A RANDOMIZED TRIAL OF DOXORUBICIN, MITOXANTRONE AND BISANTRENE IN ADVANCED BREAST-CANCER (A SOUTH-WEST-ONCOLOGY-GROUP STUDY)

被引：21

作者：

COWAN, JD

OSBORNE, CK

NEIDHART, JA

VONHOFF, DD

CONSTANZI, JJ

VAUGHN, CB

机构：

[1] UNIV TEXAS SAN ANTONIO, SAN ANTONIO, TX 78285 USA

[2] OHIO STATE UNIV HOSP, COLUMBUS, OH 43210 USA

[3] UNIV TEXAS SAN ANTONIO, MED BRANCH, GALVESTON, TX 77550 USA

[4] PROVIDENCE HOSP, SOUTHFIELD, MI 48037 USA

来源：

关键词：

D O I：

10.1007/BF00174162

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：149 / 152

页数：4

共 14 条

[1] CARBONE PP, 1977, BREAST CANCER ADV RE, P165
[2] CARTER SK, 1976, BREAST CANCER TRENDS, P193
[3] CITARELLA RV, 1980, 20TH INT C ANT AG CH
[4] MITOXANTRONE IN ADVANCED BREAST-CANCER - A PHASE-II STUDY WITH SPECIAL ATTENTION TO CARDIOTOXICITY
COLEMAN, RE
MAISEY, MN
KNIGHT, RK
RUBENS, RD
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (06): : 771 - 776
[5] JOHNSON RK, 1979, CANCER TREAT REP, V63, P425
[6] Myers J W, 1983, Invest New Drugs, V1, P85
[7] NAGEL GA, 1981, 12TH INT C CHEM FLOR
[8] OSBORNE CK, 1984, CANCER TREAT REP, V68, P357
[9] TORMEY DC, 1975, CANCER CHEMOTH REP 3, V6, P319
[10] ACTIVITY OF 9-10 ANTHRACENEDICARBOXALDEHYDE BIS[(4,5-DIHYDRO-1 H-IMIDAZOL-2-YL)HYDRAZONE]DIHYDROCHLORIDE (CL216,942) IN A HUMAN-TUMOR CLONING SYSTEM - LEADS FOR PHASE-II TRIALS IN MAN
VONHOFF, DD
COLTMAN, CA
FORSETH, B
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1981, 6 (02) : 141 - 144